Trials / Completed
CompletedNCT06884215
Human Skin Safety Testing of Mitopure Topical Products Using a Human Repeat Insult Patch Test (HRIPT) in Healthy Volunteers
A Modified Draize Repeat Insult Patch Test in a Shared Panel of 100 Healthy Volunteers to Investigate the Irritation and Sensitization Potential of Test Articles Following Repeated Cutaneous Patch Applications
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 112 (actual)
- Sponsor
- Amazentis SA · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The objective of this study is to investigate the irritation and sensitization potential of multiple topically applied test articles (containing different concentrations of Mitopure), in a shared panel of healthy volunteers by means of repeated cutaneous patch applications under occlusion based on the modified Draize method
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Mitopure Topical Formula 3 | Topical skin cream containing Mitopure |
| OTHER | Mitopure Topical Formula 4 | Topical skin cream containing Mitopure |
Timeline
- Start date
- 2025-03-17
- Primary completion
- 2025-04-28
- Completion
- 2025-04-28
- First posted
- 2025-03-19
- Last updated
- 2025-05-21
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT06884215. Inclusion in this directory is not an endorsement.